Screener
Sarepta Therapeutics, Inc. SRPT Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s accounts payable?
- Sarepta Therapeutics, Inc. (SRPT) reported accounts payable of $50.98M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s accounts payable changed year-over-year?
- Sarepta Therapeutics, Inc.'s accounts payable decreased by 62.7% year-over-year, from $136.7M to $50.98M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s accounts payable has grown at a 20.4% compound annual growth rate (CAGR), from $111.09M to $280.84M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Sarepta Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude